{"id":"W2129405414","doi":"10.1586/era.10.21","title":"Evolution of systemic therapy for advanced pancreatic cancer","year":2010,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gemcitabine; Medicine; Erlotinib; Pancreatic cancer; Oncology; Drug development; Cabozantinib; Targeted therapy; Cancer; Internal medicine; Clinical trial; Drug; Pharmacology; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007942731,0.0007328832,0.001501958,0.001893529,0.0003030344,0.0008961692,0.0008134201,0.0009833416,0.00327881],"category_scores_gemma":[0.0004828329,0.000245854,0.0006196299,0.001927717,0.000579388,0.001362052,0.0006035144,0.002531779,0.002882965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007801983,"about_ca_system_score_gemma":0.0008170405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009314793,"about_ca_topic_score_gemma":0.002488946,"domain_scores_codex":[0.9997724,0.00006281901,0.00002891189,0.00004014049,0.00008160494,0.00001407585],"domain_scores_gemma":[0.9997664,0.0001039317,0.00004148386,0.00001184618,0.0000558866,0.00002047922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007288369,0.00007202131,0.000123184,0.00785841,0.00007028058,0.0002655133,0.00004359029,0.0002954544,0.001325693,0.003195483,0.02461521,0.9620622],"study_design_scores_gemma":[0.00004603223,0.0001452506,0.0008584757,0.002449983,0.00007452007,0.002427478,0.00004028311,0.0001158798,0.0004221495,0.001936333,0.9914681,0.00001555436],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001037145,0.9981384,0.0001223941,0.0003194258,0.0001418881,0.000003849441,0.000007176068,0.000005705384,0.001157505],"genre_scores_gemma":[0.000785212,0.9974745,0.000246554,0.0004037832,0.0002020967,0.00000722976,0.00001958173,0.000002320693,0.0008586642],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00327881,"threshold_uncertainty_score":0.01096874,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06803295768521518,"score_gpt":0.4710640762374048,"score_spread":0.4030311185521896,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}